•  Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

Chromatography

 Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

Feb 09 2024

Nitrosamines are carcinogenic, even at trace levels. As a result, the FDA issued guidance regarding the monitoring of nitrosamine impurities in drugs made for human consumption. Monitoring nitrite impurities in pharmaceutical products and raw materials can be part of a control strategy for nitrosamines. Ion chromatography (IC) is well suited for the analysis of trace amounts of nitrite.

IC is an excellent method for measuring trace levels of nitrite. Unlike other testing methods, chloride does not interfere with an IC’s analysis of nitrite. Sample preparation through solid phase extraction or pre-derivatisation is therefore not necessary with IC. Additionally, IC can simultaneously detect multiple ionic impurities in drug products.

A Metrosep A Supp 10 column with UV/VIS detection is the preferred choice for the IC analysis of nitrite in pharmaceutical industry. Inline sample preparation techniques, such as the Metrohm intelligent Preconcentration Technique with Matrix Elimination (MiPCT-ME), further increase the sensitivity and robustness of the analysis. Moreover, preconcentrating the sample increases the sensitivity, allowing even trace amounts of nitrite to be detected. Matrix elimination improves the robustness by removing the interfering sample matrix.

More information online


Digital Edition

International Labmate 49.6 - Sept 2024

September 2024

Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...

View all digital editions

Events

SPICA 2024

Oct 15 2024 Milan, Italy

Lab Bangladesh

Oct 17 2024 Dhaka, Bangladesh

SETAC North America

Oct 20 2024 Fort Worth, TX, USA

HPLC

Oct 21 2024 Dalian, China

Lab Innovations 2024

Oct 30 2024 Birmingham, UK

View all events